<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0005271"><a href="http://purl.obolibrary.org/obo/MONDO_0005271">MONDO:0005271</a></h3>
<p><strong>Label:</strong> allergic disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0017853">MONDO:0017853</a> (hypersensitivity pneumonitis), <a href="http://purl.obolibrary.org/obo/MONDO_0020537">MONDO:0020537</a> (occupational allergic alveolitis), <a href="http://purl.obolibrary.org/obo/MONDO_0019315">MONDO:0019315</a> (diffuse cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019316">MONDO:0019316</a> (Maculopapular cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019624">MONDO:0019624</a> (acquired angioedema), <a href="http://purl.obolibrary.org/obo/MONDO_0019023">MONDO:0019023</a> (cutaneous mastocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019298">MONDO:0019298</a> (rare urticaria), <a href="http://purl.obolibrary.org/obo/MONDO_0019013">MONDO:0019013</a> (non-histaminic angioedema), <a href="http://purl.obolibrary.org/obo/MONDO_0020027">MONDO:0020027</a> (rare allergic disease), <a href="http://purl.obolibrary.org/obo/MONDO_0020028">MONDO:0020028</a> (rare allergic respiratory disease), <a href="http://purl.obolibrary.org/obo/MONDO_0020536">MONDO:0020536</a> (pigeon-breeder lung disease), <a href="http://purl.obolibrary.org/obo/MONDO_0004980">MONDO:0004980</a> (atopic eczema), <a href="http://purl.obolibrary.org/obo/MONDO_0011786">MONDO:0011786</a> (allergic rhinitis),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_79457">Orphanet:79457</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98050">Orphanet:98050</a>, <a href="http://www.orpha.net/ORDO/Orphanet_31740">Orphanet:31740</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98052">Orphanet:98052</a>, <a href="http://purl.obolibrary.org/obo/OMIM_147050">OMIM:147050</a>, <a href="http://purl.obolibrary.org/obo/OMIM_605803">OMIM:605803</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99908">Orphanet:99908</a>, <a href="http://purl.obolibrary.org/obo/OMIM_154800">OMIM:154800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99909">Orphanet:99909</a>, <a href="http://www.orpha.net/ORDO/Orphanet_66646">Orphanet:66646</a>, <a href="http://www.orpha.net/ORDO/Orphanet_658">Orphanet:658</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79384">Orphanet:79384</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603165">OMIM:603165</a>, <a href="http://purl.obolibrary.org/obo/OMIM_145300">OMIM:145300</a>, <a href="http://www.orpha.net/ORDO/Orphanet_91385">Orphanet:91385</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607154">OMIM:607154</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79456">Orphanet:79456</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 40.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 39.10%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 38.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) 37.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) and <a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology) 37.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000989">HP:0000989</a> (Pruritus) and <a href="http://purl.obolibrary.org/obo/HP_0002597">HP:0002597</a> (Abnormality of the vasculature) 37.07%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 28.94%</li>
<li>Thing 28.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 28.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument) 27.58%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 25.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002086">HP:0002086</a> (Abnormality of the respiratory system) 25.69%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 25.43%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) 24.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 22.68%</li>
</ul>
</body>
</html>
